NCT00246363View on ClinicalTrials.gov

A Clinical Research Study Designed To Determine If Treatment of Hepatitis C With Milk Thistle is More Effective Than No Treatment In Patients Infected With Both HIV And Hepatitis C

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 31, 2005

Primary Completion Date

December 31, 2007

Study Completion Date

December 31, 2007

Conditions

HIV InfectionsHepatitis C

Interventions

DRUG

Silymarin

Silymarin (milk thistle)

DRUG

Placebo

Trial Locations (1)

10029-6574

Mount Sinai School of Medicine, New York

All Listed Sponsors

collaborator

National Institute of Nursing Research (NINR)

NIH

lead

Henry Sacks

OTHER

NCT00246363 - A Clinical Research Study Designed To Determine If Treatment of Hepatitis C With Milk Thistle is More Effective Than No Treatment In Patients Infected With Both HIV And Hepatitis C | Biotech Hunter | Biotech Hunter